Table 2.
1 | Major criteria |
(a) | High‐degree atrioventricular block (include complete atrioventricular block) or lethal ventricular arrhythmia (persistent ventricular tachycardia, ventricular fibrillation) |
(b) | Basal septum thinning or anatomical abnormalities of ventricular wall (ventricular aneurysm, focal thinning, focal thickening) |
(c) | Left ventricular systolic dysfunction (ejection fraction <50%) or focal ventricular wall motion abnormalities |
(d) | Significant positive uptake in the heart on gallium citrate scintigraphy or 18F‐fluorodeoxyglucose positron emission tomography imaging |
(e) | Late gadolinium enhancement on cardiac magnetic resonance imaging |
2 | Minor criteria |
(f) | Ventricular arrhythmia in ECG (nonsustained ventricular tachycardia, multifocal or frequent premature ventricular contraction), bundle branch block, axis deviation, abnormal Q wave |
(g) | Focal defect on single‐photon emission computed tomography |
(h) | Monocyte infiltration and moderate‐severe fibrosis on endomyocardial biopsy |
Consider as disease highly probable clinical manifestations if ≥2 of 5 major criteria (a–e) have been met. Consider as highly probable clinical manifestations if 1 of 5 major criteria (a–e) and 2 of 3 minor criteria (f–h) have been met.